<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2023-14-2-101-104</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1819</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>3.2.7 ALLERGOLOGY AND IMMUNOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>3.2.7. АЛЛЕРГОЛОГИЯ И ИММУНОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Influence of preparations with peptides on innate and adaptive immunity</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние мезотерапевтических препаратов, содержащих пептиды на врожденный и адаптивный иммунитет</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5716-4397</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сизякина</surname><given-names>Л. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Sizyakina</surname><given-names>L. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сизякина Людмила Петровна – доктор медицинских наук, профессор, заведующий кафедрой клинической иммунологии и аллергологии.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Lyudmila P. Sizyakina - Dr. Sci. (Med.), professor, head of the department of clinical immunology and allergology. Rostov State Medical University.</p><p>Rostov-on-Done</p></bio><email xlink:type="simple">msiziakina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8897-2386</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеева</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeeva</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергеева Александра Игоревна - аспирант кафедры клинической иммунологии и аллергологии.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Alexandra I. Sergeeva - Postgraduate student of the department of clinical immunology and allergology, Rostov State Medical University.</p><p>Rostov-on-Done</p></bio><email xlink:type="simple">Aleksandra.sergeeva.87@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>26</day><month>09</month><year>2023</year></pub-date><volume>14</volume><issue>3</issue><fpage>101</fpage><lpage>104</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Sizyakina L.P., Sergeeva A.I., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Сизякина Л.П., Сергеева А.И.</copyright-holder><copyright-holder xml:lang="en">Sizyakina L.P., Sergeeva A.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1819">https://www.medicalherald.ru/jour/article/view/1819</self-uri><abstract><p>Objective: to assess the dynamics of the immune system functioning when using mesotherapy with peptide complexes. Materials and methods: the observation group consisted of 26 women (from 35 to 55 years old) who received a course of mesotherapy with preparations containing peptides for the first time. Injections were carried out in a course of 5 procedures with an interval of 14 days. The exclusion criteria were the absence of same manipulations in the past, hormone replacement therapy, combined oral contraceptives, pregnancy, lactation, acute infections, somatic pathologies. The parameters of innate and adaptive immunity were studied before the course of procedures, right after it, 3 and 6 months after the course. Skin quality changes were assessed using the Aramo Smart Lite 300 dermatoscope. Results: improved skin quality, decreased skin creases, increased skin moisture. The obtained clinical improvements last for three months after the end of the course and there is a tendency for the effects to decrease after six months. In the functioning of the immune system, there is a redistribution of lymphocytes population in the peripheral bloodstream immediately after the course of mesotherapy. In addition, an increase in peripheral T-regulatory lymphocytes responsible for intraimmune suppression was documented. The activation of spontaneous oxygen-producing activity was noted. 3 months after the procedure, no significant changes in immunological parameters were found. 6 months after the course of procedures, a decrease in the level of T-lymphocytes with an increase in the expression of markers of early T-cell activation was recorded. In the humoral link, an increase in circulating B-lymphocytes was documented. In the parameters of innate immunity, there is a decrease in the spontaneous oxygen-producing activity of neutrophils. Conclusion: as a result of the study, a positive persistent clinical effect is documented, simultaneously with the mobilization of factors of innate and adaptive immunity. It is important to note the fact that the immune response restores completely within 6 months after a course of mesotherapy with peptide complexes, with still noticeable clinical results.</p></abstract><trans-abstract xml:lang="ru"><p>Цель: оценить динамику работы модели иммунной системы при использовании мезотерапии пептидными комплексами. Материалы и методы: группу наблюдения составили 26 женщин (от 35 до 55 лет), впервые получившие курс процедур мезотерапии препаратами, содержащими пептиды. Инъекции проводились курсом 5 процедур с интервалом 14 дней. Критериями исключения являлись отсутствие подобных манипуляций в прошлом, приём заместительной гормональной терапии, комбинированных оральных контрацептивов, беременность, лактация, острые инфекции, соматические патологии. До начала курса процедур, после, спустя 3 и 6 месяцев были исследованы параметры врождённого и адаптивного иммунитета. Изменения качества кожи оценивались с помощью электронного дерматоскопа Aramo Smart Lite 300. Результаты: клинически отмечено улучшение качества кожи, что выражено в снижении глубины кожных заломов и морщин, а также в повышении параметров увлажнённости кожи. Полученные клинические улучшения сохраняются в течение трёх месяцев после окончания курса процедур и отмечена тенденция к снижению полученных эффектов через полгода. В работе иммунной системы наблюдается перераспределение в периферическом кровотоке популяционного состава лимфоидного ростка иммунопоэза сразу после курса мезотерапии. Кроме того, документируется увеличение доли периферических Т-регуляторных лимфоцитов, отвечающих за интраиммунную супрессию. Отмечена активация спонтанной кислородопродуцирующей активности. Через 3 месяца после курса процедур существенных изменений в иммунологических параметрах не выявлено. Спустя 6 месяцев после курса процедур в иммунологических показателях фиксируется снижение доли Т-лимфоцитов при увеличении экспрессии маркеров ранней Т-клеточной активации. В гуморальном звене документируется увеличение циркулирующих В-лимфоцитов. В параметрах врожденного иммунитета отмечается снижение спонтанной кислородпродуцирующей активности нейтрофилов. Заключение: в результате исследования документируется положительный стойкий клинический эффект одновременно с мобилизацией факторов врожденного и адаптивного иммунитета. Отмечается восстановление через 6 месяцев характеристик иммунного ответа после курса мезотерапии пептидными комплексами.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пептидные комплексы</kwd><kwd>мезотерапия</kwd><kwd>врожденный и адаптивный иммунитет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>peptide complexes</kwd><kwd>mesotherapy</kwd><kwd>innate and adaptive immunity</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>The relevance of this study is associated with the rapid development of cosmetological procedures in aesthetic medicine [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit2">2</xref>]. Injection techniques have entered into active use and established themselves as a leading choice in instrumental cosmetology [<xref ref-type="bibr" rid="cit3">3</xref>][<xref ref-type="bibr" rid="cit4">4</xref>][<xref ref-type="bibr" rid="cit5">5</xref>]. In particular, mesotherapy is popular for correcting age-related changes in the skin of the face and the body associated with senescence [<xref ref-type="bibr" rid="cit6">6</xref>][<xref ref-type="bibr" rid="cit7">7</xref>]. Skin aging is stipulated by both structural and functional changes, and the capability of correcting skin quality with peptide mesotherapy deserves careful consideration [<xref ref-type="bibr" rid="cit8">8</xref>][<xref ref-type="bibr" rid="cit9">9</xref>]. From the persistent clinical effect after using peptide mesotherapy cocktails logically follows the assumption about the impact of peptide complexes on the functional potential of immunocompetent cells and the homeostasis of the body as a whole [<xref ref-type="bibr" rid="cit10">10</xref>]. However, there are no literature data characterizing the indicators of the innate and adaptive immune responses that arise in reply to the injection of peptide complexes for aesthetic purposes.</p><p>The purpose of the study was to investigate changes in the functioning of the immune system prior to a mesotherapy course with peptide complexes and in 3 and 6 months after its accomplishment.</p></sec><sec><title>Materials and methods</title><p>The observation group consisted of 26 women (from 35 to 55 years old), who for the first time received a course of mesotherapy procedures with drugs containing peptides. Exclusion criteria were carrying out the same manipulations in the past, hormone replacement therapy, administration of combined oral contraceptives, pregnancy, lactation, acute infections, and somatic pathologies.</p><p>The course of mesotherapy was carried out with an interval of 14 days and consisted of 5 procedures. The Hydro Line Extra NucleoSpire Revitalizing complex B was used, the composition of which was represented by vitamins (B1, B2, B3, B4, B5, B6, B8, B9, H), L-amino acids (alanine, arginine, asparagine, glutamine, glutamic acid, glycine, histidine, cysteine, cystine, leucine, lysine, phenylalanine, methionine, proline, valine, tryptophan, serine, threonine), glutathione, micronutrients (Mg, Mn, Ni, Co, Zn, Cu, and Mo), unstabilized hyaluronic acid of biosynthetic origin, and buffer system.</p><p>Along with assessing the clinical effect, the parameters of the innate and adaptive immune responses, based on the assessment of markers CD3, CD4, CD8, CD16, CD19, CD25, and intracellular content of FoxP3, were investigated prior to the procedure course, right after its accomplishment, as well as in 3 and 6 months after the procedure accomplishment. The oxygen-dependent metabolic activity in neutrophils was assessed with the NBT test. The content of serum immunoglobulins A, M, and G were determined with the radial immunodiffusion reaction in a Mancini gel; the IgE level was determined by ELISA (enzyme-linked immunosorbent assay). The skin condition including its hydration, depth of creases and wrinkles was assessed using an Aramo Smart Lite 300 device (Korea). The investigation was carried out at the Ekaterininskaya Clinic LLC and the Network of European Laboratories LLC.</p></sec><sec><title>Results</title><p>Clinical results showed that right after the accomplishment of the mesotherapy procedure course, the quality of the skin significantly improved, which was attested by a decrease in the relief of skin creases, as at the prior stage, the examined index was up to 78.00% [ 73.00; 90.00] while after the course accomplishment, it was 45.5% [ 37.75; 53. 25], p&lt;0.0001. In addition, an increase in skin hydration parameters was also revealed, when comparing values at the prior stage of examination (55.5% [ 46.5; 62.0]) and after the procedure course accomplishment (71.0% [ 63.0; 80.2], p&lt;0.0001). Immunological indicators demonstrated a statistically significant redistribution of the subpopulation composition of the lymphoid lineage of immunopoiesis in the peripheral bloodstream. In particular, an increase in the relative number of mature T-lymphocytes and a simultaneous decrease in B-cells and CD16+ subpopulations were noted. In the cellular unit of adaptive immunity, an increase in both CD4+ and CD8+ subpopulations was manifested. Besides, a decrease in the amount of T cells with CD25 expression was revealed, which attested to the process of early T cell activation. Furthermore, a statistically significant increase in the proportion of peripheral regulatory T-lymphocytes CD4+CD25+FoxP3+ was found, which are responsible for intraimmune suppression. In the data of the general blood test, a decrease in the total amount of leukocytes in peripheral blood flow was revealed, as at the prior stage, the examined index was 6.30 [ 4.88; 7.12],10⁹/l and then it reached the value 5.40 [ 4.62; 6.28],10⁹/l; p=0.0016 right after the course accomplishment. A decrease in lymphocytes was also found: at the prior stage, the examined index was 36.00 [ 30.00; 44.00], 10⁹/l and reached the value 28.50 [ 23.00; 34.75]; p=0.0004 after procedure accomplishment. Thus, the absolute values of the total number of T cells and their subpopulation characteristics were reduced. The cellular component of the humoral adaptive immune response was manifested by a decrease in the relative and absolute content of B lymphocytes. Nevertheless, the activation of antibody production was revealed attested by an increase in the level of all classes (IgA, IgM, IgG, IgE) of serum immunoglobulins. Indicators of the innate immune response were characterized by a decrease in the number of circulating immune complexes in both absolute and relative values. Activation of spontaneous oxygen-producing activity was shown in the neutrophil unit accompanied by no changes under conditions of additional neutrophil stimulation.</p><p>In 3 months after the accomplishment of the mesotherapy course, no significant changes in the clinical picture were recorded. In particular, parameters characterizing the depth of skin creases were 45.5% [ 37.75; 53.25] and 45.50% [ 38.00; 58.00], p&lt;0.0001 at stages right after the accomplishment of course procedures and 3 months later, respectively. The hydration index was 71.0% [ 63.0; 80.2] right after the accomplishment of course procedures and in 3 months it was 60.50% [ 51.75; 70.00] p&lt;0.0001. There were no changes noted in the immunological indicators, which reflect the characteristics of the quantitative and functional potencies of the immune system, when compared with the results recorded at the stage right after the accomplishment of the procedure course.</p><p>In 6 months after the accomplishment of the course, the indicators of the clinical picture manifested a tendency toward a decrease in the achieved effects. An increase in the depth of skin creases and wrinkles was revealed as right after the accomplishment of the procedure course the examined index was 45.5% [ 37.75; 53.25] while in 6 months it was 63.0% [ 45.5; 68.5], p &lt;0.0001. Besides, a decrease in skin hydration parameters was noted, as right after the accomplishment of the procedure course the examined index was 71.0% [ 63.0; 80.2], and in 6 months it was 49.5% [ 42.7; 55.2]; p &lt;0.0001.</p><p>Immunological parameters manifested a decrease in the proportion of T-lymphocytes when comparing results obtained right after the course accomplishment (68.00 [ 64.50; 70.25]%) and after the three-month period (65.00 [ 60.00; 67.75]%, p = 0.0387). That decrease was mediated by both CD4+ and CD8+ subpopulations when comparing values for CD4+ obtained right after the course accomplishment (36.00 [ 34.00; 37.25]%) and three months later (33.50 [ 32.00; 35.25]%, p=0.0032); and values for CD8+ obtained right after the course accomplishment (34.00[  31.00; 36.25]%, and three months later (32.00 [ 29.50; 35.00]%, p=0.0038). At the same time, there was also noted an increase in the expression of markers of early T-cell activation CD3+CD25+ when comparing results obtained right after the course accomplishment (0.08 [ 0.07; 0.11], 10⁹/l) and three months later (0.12 [ 0.09; 0.17] 10⁹/l, p=0.0097). In addition, the absolute number of T-regulatory lymphocytes (CD4+CD25+FoxP3+) increased, as right after the course accomplishment, the examined index was 0.08 [ 0.07; 0.10], 10⁹/l and three months later it was 0.09 [ 0.08; 0.13], 10⁹/l, p=0.0019. In the humoral part of the immune response, there was an increase in circulating B-lymphocytes when comparing results obtained right after the course accomplishment (0.31 [ 0.24; 0.42], 10⁹/l) and three months later (0.45 [ 0.33; 0.52], 10⁹/l, p=0.0011). In addition, a decrease in antibody production was noted, which was only confirmed for IgG, as the value right after the course accomplishment was 15.25 [ 12.88; 16.92], g/l, and three months later it was 13.80 [ 12.08; 16.15], g/l, p=0.0387. In the innate immune system, an increase in the number of natural killer cells was revealed when comparing results obtained right after course accomplishment (0.18 [ 0.13; 0.24], 10⁹/l) and in three months (0.24 [ 0.20; 0.33], 10⁹/l, p = 0,0032). Moreover, the spontaneous oxygen-producing activity of neutrophils also decreased when comparing NSTsp. right after natural killer course accomplishment (10.00 [ 7.75; 12.00] a.u.) and in three months (8.00 [ 5.75; 10.00], p=0.0097). Thus, based on the dynamics of changes described above, in 6 months after the natural killer course accomplishment, no statistically significant differences were identified.</p></sec><sec><title>Discussion</title><p>Mesotherapy involves a course of intradermal injections of drugs for aesthetic purposes. The obtained clinical results, recorded using electronic dermatoscopy, confirm that the patients achieved a positive and lasting cosmetic effect after a course of mesotherapy with peptide complexes related to a significant improvement in skin quality. Due to the fact that peptide complexes with an immunotropic effect were used, it has been logical to assume their possible effect on innate and adaptive immunity and the impact on the homeostasis of the body as a whole. The results of the study make it possible to confirm the involvement of innate and adaptive immunity, which is reflected in the processes of differentiation of lymphocyte populations and in a decrease in activation potential. An increase in antibody production and activation of spontaneous oxygen-producing activity were revealed right after the procedure course accomplishment. When specifying the parameters of the innate immune response, a decrease in the number of natural killer cells was found, as well as a tendency to an increase in the oxygen-dependent mechanisms of neutrophil phagocytosis was noted. These changes in the functioning of the immune system were stable for 3 months after the accomplishment of the course of mesotherapy procedures and returned to previous parameters six months later.</p></sec><sec><title>Conclusion</title><p>As a result of the study, an improvement in skin quality after procedures of the mesotherapy course and long-term preservation of the effects was documented, as well as the dynamics of changes in both the innate and adaptive immune units were noted after a course of peptide administration. It is important to note the fact of the complete restoration of the characteristics of the immune status after 6 months, with noticeably lasting clinical results after the accomplishment of the procedure course.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Королькова Т.Н., Гома С.Е. Изучение влияния мезотерапии пептидами эпифиза на влажность и эластичность кожи. Российский журнал кожных и венерических болезней. 2017;20(5):305-310. https://doi.org/10.18821/1560-9588-2017-20-5-305-310</mixed-citation><mixed-citation xml:lang="en">Korolkova T.N., Goma S.E. Study of the mesotherapy effect with epiphysis peptides on the moisture and elasticity of the skin. Russian Journal of Skin and Venereal Diseases. 2017;20(5):305-310. (In Russ.) https://doi.org/10.18821/1560-9588-2017-20-5-305-310</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ходаченко В.В., Сизякина Л.П., Сидоренко О.А. Эффекты ботулинического токсина типа А при инволюционных изменениях кожи (клинико-иммунологическое исследование). Цитокины и воспаление. 2014;13(3):141-142. eLIBRARY ID: 22840563</mixed-citation><mixed-citation xml:lang="en">Khodachenko V.V., Sizyakina L.P., Sidorenko O.A. Effects of botulinum toxin type A in involutive skin changes (clinical and immunological study). Cytokines and inflammation. 2014;13(3):141-142. (In Russ.) eLIBRARY ID: 22840563</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мантурова Н.Е., Стенько А.Г., Петинати Я.А., Чайковская Е.А., Болгарина А.А. Инъекционный коллаген в коррекции возрастных изменений кожи: экспериментально-клинические параллели. Вестник РГМУ. 2019;(1):78–85. https://doi.org/10.24075/vrgmu.2019.010</mixed-citation><mixed-citation xml:lang="en">Manturova N.E., Stenko A.G., Petinati Y.A., Chaikovskaya E.A., Bolgarina A.A. Injectable collagen in correction of age-related skin changes: experimental and clinical parallels. Bulletin of RSMU. 2019;(1):71–7. (In Russ.) https://doi.org/10.24075/vrgmu.2019.010</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Караулов А.В., Юцковский А.Д. Клиническая иммунология в дерматовенерологии и косметологии. Владивосток: Медицина ДВ, 2013.</mixed-citation><mixed-citation xml:lang="en">Karaulov A.V., Yutskovsky A.D. Clinical immunology in dermatovenerology and cosmetology. Vladivostok: Medicine DV, 2013. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Brun C, Jean-Louis F, Oddos T, Bagot M, Bensussan A, Michel L. Phenotypic and functional changes in dermal primary fibroblasts isolated from intrinsically aged human skin. Exp Dermatol. 2016;25(2):113-9. https://doi.org/10.1111/exd.12874</mixed-citation><mixed-citation xml:lang="en">Brun C, Jean-Louis F, Oddos T, Bagot M, Bensussan A, Michel L. Phenotypic and functional changes in dermal primary fibroblasts isolated from intrinsically aged human skin. Exp Dermatol. 2016;25(2):113-9. https://doi.org/10.1111/exd.12874</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chadli L, Sotthewes B, Li K, Andersen SN, Cahir-McFarland E, et al. Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients. Sci Rep. 2019;9(1):4521. https://doi.org/10.1038/s41598-019-41153-w</mixed-citation><mixed-citation xml:lang="en">Chadli L, Sotthewes B, Li K, Andersen SN, Cahir-McFarland E, et al. Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients. Sci Rep. 2019;9(1):4521. https://doi.org/10.1038/s41598-019-41153-w</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hatanaka T, Kawakami K, Uraji M. Inhibitory effect of collagen-derived tripeptides on dipeptidylpeptidase-IV activity. J Enzyme Inhib Med Chem. 2014;29(6):823-8. https://doi.org/10.3109/14756366.2013.858143</mixed-citation><mixed-citation xml:lang="en">Hatanaka T, Kawakami K, Uraji M. Inhibitory effect of collagen-derived tripeptides on dipeptidylpeptidase-IV activity. J Enzyme Inhib Med Chem. 2014;29(6):823-8. https://doi.org/10.3109/14756366.2013.858143</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Edgar S, Hopley B, Genovese L, Sibilla S, Laight D, Shute J. Effects of collagen-derived bioactive peptides and natural antioxidant compounds on proliferation and matrix protein synthesis by cultured normal human dermal fibroblasts. Sci Rep. 2018;8(1):10474. https://doi.org/10.1038/s41598-018-28492-w</mixed-citation><mixed-citation xml:lang="en">Edgar S, Hopley B, Genovese L, Sibilla S, Laight D, Shute J. Effects of collagen-derived bioactive peptides and natural antioxidant compounds on proliferation and matrix protein synthesis by cultured normal human dermal fibroblasts. Sci Rep. 2018;8(1):10474. https://doi.org/10.1038/s41598-018-28492-w</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">El-Domyati M, El-Ammawi TS, Moawad O, El-Fakahany H, Medhat W, et al. Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol. 2012;51(8):913-9. https://doi.org/10.1111/j.1365-4632.2011.05184.x</mixed-citation><mixed-citation xml:lang="en">El-Domyati M, El-Ammawi TS, Moawad O, El-Fakahany H, Medhat W, et al. Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol. 2012;51(8):913-9. https://doi.org/10.1111/j.1365-4632.2011.05184.x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Prikhnenko S. Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality. Clin Cosmet Investig Dermatol. 2015;8:151-7. https://doi.org/10.2147/CCID.S76721</mixed-citation><mixed-citation xml:lang="en">Prikhnenko S. Polycomponent mesotherapy formulations for the treatment of skin aging and improvement of skin quality. Clin Cosmet Investig Dermatol. 2015;8:151-7. https://doi.org/10.2147/CCID.S76721</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
